Revising the mechanism of p75NTR activation: intrinsically monomeric state of death domains invokes the "helper" hypothesis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 08 2020
Historique:
received: 22 04 2020
accepted: 27 07 2020
entrez: 15 8 2020
pubmed: 15 8 2020
medline: 12 1 2021
Statut: epublish

Résumé

The neurotrophin receptor p75NTR plays crucial roles in neuron development and regulates important neuronal processes like degeneration, apoptosis and cell survival. At the same time the detailed mechanism of signal transduction is unclear. One of the main hypotheses known as the snail-tong mechanism assumes that in the inactive state, the death domains interact with each other and in response to ligand binding there is a conformational change leading to their exposure. Here, we show that neither rat nor human p75NTR death domains homodimerize in solution. Moreover, there is no interaction between the death domains in a more native context: the dimerization of transmembrane domains in liposomes and the presence of activating mutation in extracellular juxtamembrane region do not lead to intracellular domain interaction. These findings suggest that the activation mechanism of p75NTR should be revised. Thus, we propose a novel model of p75NTR functioning based on interaction with "helper" protein.

Identifiants

pubmed: 32792564
doi: 10.1038/s41598-020-70721-8
pii: 10.1038/s41598-020-70721-8
pmc: PMC7427093
doi:

Substances chimiques

Ligands 0
Liposomes 0
NGFR protein, human 0
Nerve Tissue Proteins 0
Receptors, Growth Factor 0
Receptors, Nerve Growth Factor 0
Ngfr protein, rat 136958-07-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13686

Références

Bibel, M. & Barde, Y.-A. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev.14, 2919–2937 (2000).
pubmed: 11114882
Chao, M. V. Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat. Rev. Neurosci.4, 299–309 (2003).
pubmed: 12671646
Ibáñez, C. F. & Simi, A. p75 neurotrophin receptor signaling in nervous system injury and degeneration: Paradox and opportunity. Trends Neurosci.35, 431–440 (2012).
pubmed: 22503537
Lee, R., Kermani, P., Teng, K. K. & Hempstead, B. L. Regulation of cell survival by secreted proneurotrophins. Science294, 1945–1948 (2001).
pubmed: 11729324
Vicario, A., Kisiswa, L., Tann, J. Y., Kelly, C. E. & Ibáñez, C. F. Neuron-type-specific signaling by the p75NTR death receptor is regulated by differential proteolytic cleavage. J. Cell. Sci.128, 1507–1517 (2015).
pubmed: 25720379
Yoon, S. O., Casaccia-Bonnefil, P., Carter, B. & Chao, M. V. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J. Neurosci.18, 3273–3281 (1998).
pubmed: 9547236 pmcid: 6792655
Meier, S. et al. The p75 neurotrophin receptor is required for the survival of neuronal progenitors and normal formation of the basal forebrain, striatum, thalamus and neocortex. Development146, 20 (2019).
Roux, P. P. & Barker, P. A. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol.67, 203–233 (2002).
pubmed: 12169297
Dechant, G. & Barde, Y.-A. The neurotrophin receptor p75(NTR): Novel functions and implications for diseases of the nervous system. Nat. Neurosci.5, 1131–1136 (2002).
pubmed: 12404007
Kraemer, B. R., Yoon, S. O. & Carter, B. D. The biological functions and signaling mechanisms of the p75 neurotrophin receptor. In Neurotrophic Factors (eds Lewin, G. R. & Carter, B. D.) 121–164 (Springer, Berlin, 2014).
Vilar, M. Chapter four–structural characterization of the p75 neurotrophin receptor: A stranger in the TNFR superfamily. In Vitamins and Hormones, Vol. 104 (ed. Litwack, G.) 57–87 (Academic Press, New York, 2017).
Tanaka, K., Kelly, C. E., Goh, K. Y., Lim, K. B. & Ibáñez, C. F. Death domain signaling by disulfide-linked dimers of the p75 neurotrophin receptor mediates neuronal death in the CNS. J. Neurosci.36, 5587–5595 (2016).
pubmed: 27194337 pmcid: 6601771
Vilar, M. et al. Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron62, 72–83 (2009).
pubmed: 19376068 pmcid: 2810632
Lin, Z. et al. Structural basis of death domain signaling in the p75 neurotrophin receptor. Elife4, e11692 (2015).
pubmed: 26646181 pmcid: 4739766
Qu, Q. et al. Structural characterization of the self-association of the death domain of p75NTR. PLoS One8, e57839 (2013).
pubmed: 23472109 pmcid: 3589453
Vilar, M. et al. Heterodimerization of p45–p75 modulates p75 signaling: Structural basis and mechanism of action. PLoS Biol.12, e1001918 (2014).
pubmed: 25093680 pmcid: 4122344
Anastasia, A., Barker, P. A., Chao, M. V. & Hempstead, B. L. Detection of p75NTR trimers: Implications for receptor stoichiometry and activation. J. Neurosci.35, 11911–11920 (2015).
pubmed: 26311773 pmcid: 4549402
Liepinsh, E., Ilag, L. L., Otting, G. & Ibáñez, C. F. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J.16, 4999–5005 (1997).
pubmed: 9305641 pmcid: 1170134
Mineev, K. S., Nadezhdin, K. D., Goncharuk, S. A. & Arseniev, A. S. Façade detergents as bicelle rim-forming agents for solution NMR spectroscopy. Nanotechnol. Rev.6, 93–103 (2017).
Mineev, K. S., Goncharuk, S. A., Kuzmichev, P. K., Vilar, M. & Arseniev, A. S. NMR dynamics of transmembrane and intracellular domains of p75NTR in lipid-protein nanodiscs. Biophys. J.109, 772–782 (2015).
pubmed: 26287629 pmcid: 4547337
Vilar, M. et al. Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J. Cell. Sci.122, 3351–3357 (2009).
pubmed: 19706676 pmcid: 2736866
Tyn, M. T. & Gusek, T. W. Prediction of diffusion coefficients of proteins. Biotechnol. Bioeng.35, 327–338 (1990).
pubmed: 18592527
Garcı́a de la Torre, J. S., Huertas, M. L. & Carrasco, B. HYDRONMR: Prediction of NMR relaxation of globular proteins from atomic-level structures and hydrodynamic calculations. J. Magn. Reson.147, 138–146 (2000).
pubmed: 11042057
Rabanal, F., DeGrado, W. F. & Dutton, P. L. Use of 2,2′-dithiobis(5-nitropyridine) for the heterodimerization of cysteine containing peptides. Introduction of the 5-nitro-2-pyridinesulfenyl group. Tetrahedron Lett.37, 1347–1350 (1996).
Tyler-Cross, R. & Schirch, V. Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. J. Biol. Chem.266, 22549–22556 (1991).
pubmed: 1939272
Khursigara, G. et al. A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J. Neurosci.21, 5854–5863 (2001).
pubmed: 11487608 pmcid: 6763175
Charalampopoulos, I. et al. Genetic dissection of neurotrophin signaling through the p75 neurotrophin receptor. Cell Rep.2, 1563–1570 (2012).
pubmed: 23260665
Shen, Y. & Bax, A. Protein structural information derived from NMR chemical shift with the neural network program TALOS-N. Methods Mol. Biol.1260, 17–32 (2015).
pubmed: 25502373 pmcid: 4319698
Chill, J. H., Louis, J. M., Baber, J. L. & Bax, A. Measurement of 15N relaxation in the detergent-solubilized tetrameric KcsA potassium channel. J. Biomol. NMR36, 123–136 (2006).
pubmed: 17013683
Lindner, H. & Helliger, W. Age-dependent deamidation of asparagine residues in proteins. Exp. Gerontol.36, 1551–1563 (2001).
pubmed: 11525877
Robinson, A. B. & Robinson, L. R. Distribution of glutamine and asparagine residues and their near neighbors in peptides and proteins. PNAS88, 8880–8884 (1991).
pubmed: 1924347
Robinson, N. E. & Robinson, A. B. Deamidation of human proteins. PNAS98, 12409–12413 (2001).
pubmed: 11606750
Robinson, N. E. & Robinson, A. B. Molecular clocks. Proc. Natl. Acad. Sci. USA98, 944–949 (2001).
pubmed: 11158575
Bandi, S., Singh, S. M., Shah, D. D., Upadhyay, V. & Mallela, K. M. G. 2D NMR analysis of the effect of asparagine deamidation versus methionine oxidation on the structure, stability, aggregation, and function of a therapeutic protein. Mol. Pharm. https://doi.org/10.1021/acs.molpharmaceut.9b00719 (2019).
doi: 10.1021/acs.molpharmaceut.9b00719 pubmed: 31483994
Dunkelberger, E. B. et al. Deamidation accelerates amyloid formation and alters amylin fiber structure. J. Am. Chem. Soc.134, 12658–12667 (2012).
pubmed: 22734583 pmcid: 3410046
Hao, P., Adav, S. S., Gallart-Palau, X. & Sze, S. K. Recent advances in mass spectrometric analysis of protein deamidation. Mass Spectrom. Rev.36, 677–692 (2017).
pubmed: 26763661
Li, M. et al. Aberrant post-translational modifications compromise human myosin motor function in old age. Aging Cell14, 228–235 (2015).
pubmed: 25645586 pmcid: 4364835
Solstad, T. & Flatmark, T. Microheterogeneity of recombinant human phenylalanine hydroxylase as a result of nonenzymatic deamidations of labile amide containing amino acids. Effects on catalytic and stability properties. Eur. J. Biochem.267, 6302–6310 (2000).
pubmed: 11012685
Mishra, P. K. K. & Mahawar, M. PIMT-mediated protein repair: Mechanism and implications. Biochem. Moscow84, 453–463 (2019).
Marchetti, L. et al. Fast-diffusing p75NTR monomers support apoptosis and growth cone collapse by neurotrophin ligands. Proc. Natl. Acad. Sci. USA https://doi.org/10.1073/pnas.1902790116 (2019).
doi: 10.1073/pnas.1902790116 pubmed: 31548413
Sykes, A. M. et al. The effects of transmembrane sequence and dimerization on cleavage of the p75 neurotrophin receptor by γ-secretase. J. Biol. Chem.287, 43810–43824 (2012).
pubmed: 23105112 pmcid: 3527965
Bilderback, T. R., Grigsby, R. J. & Dobrowsky, R. T. Association of p75 NTR with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J. Biol. Chem.272, 10922–10927 (1997).
pubmed: 9099750
Chang, M.-S., Arevalo, J. C. & Chao, M. V. Ternary complex with Trk, p75, and an ankyrin-rich membrane spanning protein. J. Neurosci. Res.78, 186–192 (2004).
pubmed: 15378608
Deinhardt, K. et al. Neuronal growth cone retraction relies upon proneurotrophin receptor signaling through Rac. Sci. Signal4, ra82 (2011).
pubmed: 22155786 pmcid: 3360552
Meabon, J. S. et al. LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments. J. Biol. Chem.290, 9511–9520 (2015).
pubmed: 25666623 pmcid: 4392256
Mi, S. et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci.7, 221–228 (2004).
pubmed: 14966521
Nykjaer, A. et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature427, 843–848 (2004).
pubmed: 14985763
Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R. & He, Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature420, 74–78 (2002).
pubmed: 12422217
Khursigara, G., Orlinick, J. R. & Chao, M. V. Association of the p75 neurotrophin receptor with TRAF6. J. Biol. Chem.274, 2597–2600 (1999).
pubmed: 9915784
Shonukan, T., Bagayogo, I., McCrea, P. D., Chao, M. & Hempstead, B. Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin. Oncogene22, 3616–3623 (2003).
pubmed: 12789270
Ye, X. et al. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J. Biol. Chem.274, 30202–30208 (1999).
pubmed: 10514511
Coulson, E. J. et al. The role of neurotransmission and the Chopper domain in p75 neurotrophin receptor death signaling. Prog. Brain Res.146, 41–62 (2004).
pubmed: 14699955
Sachs, B. D. et al. p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell. Biol.177, 1119–1132 (2007).
pubmed: 17576803 pmcid: 2064370
Prats, R. & de Pedro, M. A. Normal growth and division of Escherichia coli with a reduced amount of murein. J. Bacteriol.171, 3740–3745 (1989).
pubmed: 2500418 pmcid: 210119
Kucerka, N., Kiselev, M. A. & Balgavý, P. Determination of bilayer thickness and lipid surface area in unilamellar dimyristoylphosphatidylcholine vesicles from small-angle neutron scattering curves: A comparison of evaluation methods. Eur. Biophys. J.33, 328–334 (2004).
pubmed: 12955364
Lescop, E., Schanda, P. & Brutscher, B. A set of BEST triple-resonance experiments for time-optimized protein resonance assignment. J. Magn. Reson.187, 163–169 (2007).
pubmed: 17468025
Favier, A. & Brutscher, B. Recovering lost magnetization: Polarization enhancement in biomolecular NMR. J. Biomol. NMR49, 9–15 (2011).
pubmed: 21190063
Mayzel, M., Kazimierczuk, K. & Orekhov, V. Y. The causality principle in the reconstruction of sparse NMR spectra. Chem. Commun. (Camb.)50, 8947–8950 (2014).
Zheng, G. & Price, W. S. Simultaneous convection compensation and solvent suppression in biomolecular NMR diffusion experiments. J. Biomol. NMR45, 295–299 (2009).
pubmed: 19697137

Auteurs

Sergey A Goncharuk (SA)

Laboratory of Biomolecular NMR Spectroscopy, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia. ms.goncharuk@gmail.com.

Lilya E Artemieva (LE)

Laboratory of Biomolecular NMR Spectroscopy, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.
Phystech School of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia.

Kirill D Nadezhdin (KD)

Laboratory of Biomolecular NMR Spectroscopy, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.

Alexander S Arseniev (AS)

Laboratory of Biomolecular NMR Spectroscopy, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.

Konstantin S Mineev (KS)

Laboratory of Biomolecular NMR Spectroscopy, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia. mineev@nmr.ru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH